AtriCure (NASDAQ:ATRC) Updates FY23 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective lifted by equities research analysts at BTIG Research from $56.00 to $68.00 in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. BTIG Research’s price objective points to a potential upside of 17.79% from the stock’s current price. A number of other […]
AtriCure (NASDAQ:ATRC – Get Free Report) posted its earnings results on Tuesday. The medical device company reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.15, Briefing.com reports. AtriCure had a negative return on equity of 7.15% and a negative net margin of 7.67%. The company had revenue of […]
AtriCure (NASDAQ:ATRC – Get Free Report) updated its FY 2023 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of -$0.94–$0.92 for the period, compared to the consensus estimate of -$1.02. The company issued revenue guidance of $392.00 million-$395.00 million, compared to the consensus revenue estimate of $388.31 million. AtriCure also updated […]
CM Wealth Advisors LLC purchased a new stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 9,924 shares of the medical device company’s stock, valued at approximately $419,000. Several other institutional investors and hedge funds […]